Corbus Pharmaceuticals Holdings, Inc. Earnings Per Share (Basic)
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Earnings Per Share (Basic) of -$1.81 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- Corbus Pharmaceuticals Holdings, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$1.81.
- Corbus Pharmaceuticals Holdings, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$1.23.
- Corbus Pharmaceuticals Holdings, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$1.90.
- Corbus Pharmaceuticals Holdings, Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$1.44.
- Corbus Pharmaceuticals Holdings, Inc. earnings per share, basic for fiscal 2025 was -$5.90.
- Corbus Pharmaceuticals Holdings, Inc. earnings per share, basic for fiscal 2024 was -$3.68.
- Corbus Pharmaceuticals Holdings, Inc. earnings per share, basic for fiscal 2023 was -$10.31.
- Corbus Pharmaceuticals Holdings, Inc. earnings per share, basic for fiscal 2022 was -$10.15.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.81 10-Q · filed 2026-08-06 | -$3.04 10-Q · filed 2026-08-06 | ||||||
| 2026-03-31 | -$1.23 10-Q · filed 2026-05-12 | |||||||
| 2025-12-31 | -$5.90 10-K · filed 2026-03-09 | |||||||
| 2025-09-30 | -$1.90 10-Q · filed 2025-11-12 | -$4.73 10-Q · filed 2025-11-12 | ||||||
| 2025-06-30 | -$1.44 10-Q · filed 2026-08-06 | -$2.83 10-Q · filed 2026-08-06 | ||||||
| 2025-03-31 | -$1.39 10-Q · filed 2026-05-12 | |||||||
| 2024-12-31 | -$3.68 10-K · filed 2026-03-09 | |||||||
| 2024-09-30 | -$1.15 10-Q · filed 2025-11-12 | -$2.92 10-Q · filed 2025-11-12 | ||||||
| 2024-06-30 | -$0.90 10-Q · filed 2025-08-05 | -$1.75 10-Q · filed 2025-08-05 | ||||||
| 2024-03-31 | -$0.83 10-Q · filed 2025-05-06 | |||||||
| 2023-12-31 | -$10.31 10-K · filed 2025-03-11 | |||||||
| 2023-09-30 | -$2.27 10-Q · filed 2024-11-07 | -$8.52 10-Q · filed 2024-11-07 | ||||||
| 2023-06-30 | -$2.05 10-Q · filed 2024-08-06 | -$6.27 10-Q · filed 2024-08-06 | ||||||
| 2023-03-31 | -$4.24 10-Q · filed 2024-05-07 | |||||||
| 2022-12-31 | -$10.15 10-K · filed 2024-03-12 | |||||||
| 2022-09-30 | -$2.11 10-Q · filed 2023-11-07 | -$0.07 10-Q · filed 2022-11-08 | -$7.55 10-Q · filed 2023-11-07 | -$0.25 10-Q · filed 2022-11-08 | ||||
| 2022-06-30 | -$3.18 10-Q · filed 2023-08-08 | -$0.11 10-Q · filed 2022-08-09 | -$5.44 10-Q · filed 2023-08-08 | -$0.18 10-Q · filed 2022-08-09 | ||||
| 2022-03-31 | -$2.26 10-Q · filed 2023-05-09 | -$0.08 10-Q · filed 2022-05-10 | ||||||
| 2021-12-31 | -$11.15 10-K · filed 2023-03-07 | -$0.37 10-K · filed 2022-03-08 | ||||||
| 2021-09-30 | -$0.02 10-Q · filed 2022-11-08 | -$0.29 10-Q · filed 2022-11-08 | ||||||
| 2021-06-30 | -$0.15 10-Q · filed 2022-08-09 | -$0.28 10-Q · filed 2022-08-09 | ||||||
| 2021-03-31 | -$0.14 10-Q · filed 2022-05-10 | |||||||
| 2020-12-31 | -$1.42 10-K · filed 2022-03-08 | |||||||
| 2020-09-30 | -$0.43 10-Q · filed 2021-11-12 | -$1.37 10-Q · filed 2021-11-12 | ||||||
| 2020-06-30 | -$0.52 10-Q · filed 2021-08-12 | -$0.95 10-Q · filed 2021-08-12 | ||||||
| 2019-06-30 | $0.03 10-Q/A · filed 2020-08-31 | -$0.38 10-Q/A · filed 2020-08-31 | ||||||
| 2018-06-30 | -$0.21 10-Q · filed 2019-08-08 | -$0.42 10-Q · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |